As for other general form of osteopetrosis, a clinical trial on interferon gamma −1b for intermediate osteopetrosis had just completed its phase 2 in April 2019, and results are pending (ACTIMMUNE in Intermediate Osteopetrosis; ClinicalTrials.gov Identifier: NCT02666768). This evidence concerns the gene IFNG and osteopetrosis.